Technical Note: Use of commercial multilayer Faraday cup for offline daily beam range verification at the McLaren Proton Therapy Center.

Purpose: Daily verification of the proton beam range in proton radiation therapy is a vital part of the quality assurance (QA) program. The objective of this work is to study the use of a multilayer Faraday cup (MLFC) to perform a quick and precise daily range verification of proton beams produced by a synchrotron.

Methods: Proton beam depth dose measurements were performed at room iso-center in water using PTW water tank and Bragg Peak ion chamber.

Characterization of a GEM-based scintillation detector with He-CF4 gas mixture in clinical proton beams.

Accurate, high-spatial resolution dosimetry in proton therapy is a time consuming task, and may be challenging in the case of small fields, due to the lack of adequate instrumentation. The purpose of this work is to develop a novel dose imaging detector with high spatial resolution and tissue equivalent response to dose in the Bragg peak, suitable for beam commissioning and quality assurance measurements. A scintillation gas electron multiplier (GEM) detector based on a double GEM amplification structure with optical readout was filled with a He/CF4 gas mixture and evaluated in pristine and modulated proton beams of several penetration ranges.

Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.

Considerable evidence now exists to show that that the relative biological effectiveness (RBE) changes considerably along the proton depth-dose distribution, with progressively higher RBE values at the distal part of the modulated, or spread out Bragg peak (SOBP) and in the distal dose fall-off (DDF). However, the highly variable nature of the existing studies (with regards to cell lines, and to the physical properties and dosimetry of the various proton beams) precludes any consensus regarding the RBE weighting factor at any position in the depth-dose profile. We have thus conducted a systematic study on the variation in RBE for cell killing for two clinical modulated proton beams at Indiana University and have determined the relationship between the RBE and the dose-averaged linear energy transfer (LETd) of the protons at various positions along the depth-dose profiles.

SU-E-T-491: A FLUKA Monte Carlo Computational Model of a Scanning Proton Beam Therapy Nozzle at IU Proton Therapy Center.

Purpose: Charged particle therapy, especially proton therapy is a growing treatment modality worldwide. Monte Carlo (MC) simulation of the interactions of proton beam with equipment, devices and patient is a highly efficient tool that can substitute measurements for complex and unrealistic experiments. The purpose of this study is to design a MC model of a treatment nozzle to characterize the proton scanning beam and commissioning the model for the Indiana University Health Proton Therapy Center (IUHPTC.

Beam characteristics in two different proton uniform scanning systems: a side-by-side comparison.

Purpose: To compare clinically relevant dosimetric characteristics of proton therapy fields produced by two uniform scanning systems that have a number of similar hardware components but employ different techniques of beam spreading.

Methods: This work compares two technologically distinct systems implementing a method of uniform scanning and layer stacking that has been developed independently at Indiana University (IU) and by Ion Beam Applications, S. A.

Dose Imaging Detectors for Radiotherapy Based on Gas Electron Multipliers.

New techniques in charged particle therapy and widespread use of modern dynamic beam delivery systems demand new beam monitoring devices as well as accurate 2D dosimetry systems to verify the delivered dose distribution. We are developing dose imaging detectors based on gas electron multipliers (GEM) with the goal of improving dose measurement linearity, position and timing resolution, and to ultimately allow pre-treatment verification of dose distributions and dose delivery monitoring employing scanning beam technology. A prototype 10×10 cm(2) double-GEM detector has been tested in the 205 MeV proton beam using electronic and optical readout modes.

Energy spectrum control for modulated proton beams.

In proton therapy delivered with range modulated beams, the energy spectrum of protons entering the delivery nozzle can affect the dose uniformity within the target region and the dose gradient around its periphery. For a cyclotron with a fixed extraction energy, a rangeshifter is used to change the energy but this produces increasing energy spreads for decreasing energies. This study investigated the magnitude of the effects of different energy spreads on dose uniformity and distal edge dose gradient and determined the limits for controlling the incident spectrum.

Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking.

A proton beam delivery system on a gantry with continuous uniform scanning and dose layer stacking at the Midwest Proton Radiotherapy Institute has been commissioned and accepted for clinical use. This paper was motivated by a lack of guidance on the testing and characterization for clinical uniform scanning systems. As such, it describes how these tasks were performed with a uniform scanning beam delivery system.

Multichannel detectors for profile measurements in clinical proton fields.

Two beam profile measurement detectors have been developed at Indiana University Cyclotron Facility to address the need for a tool to efficiently verify dose distributions created with active methods of clinical proton beam delivery. The multipad ionization chamber (MPIC) has 128 ionization chambers arranged in one plane and is designed to measure lateral profiles in fields up to 38 cm in diameter. The MPIC pads have a 5 mm pitch for fields up to 20 cm in diameter and a 7 mm pitch for larger fields, providing the accuracy of field size determination about 0.

Measurement of the activity of 11C and 22Na sources using a 4pi-beta-gamma coincidence system.

Many radiation applications, including positron emission tomography (PET) studies and activation dosimetry, require the knowledge of the activity of short-lived radionuclide samples, whereas relative measurements may be hampered by the absence of a reference source. Using 11C radionuclide as an example, an analytical model based on a probabilistic approach has been set up to predict the activity of a pure positron emitter measured using the 4pi-beta-gamma coincidence technique. The model has been extended to describe the measurement on a 22Na source used to test the measurement technique.

Verification of absolute ionization chamber dosimetry in a proton beam using carbon activation measurements.

Reference ionization chamber dosimetry implemented in a clinical proton beam and based on the ICRU 59 recommendations has been verified with an independent carbon activation method. The 12C(p,pn)11C nuclear reaction was used to measure the beam fluence and entrance dose. A method to transfer from the entrance dose to the dose at the ion chamber calibration position has been developed.

A compact ridge filter for spread out Bragg peak production in pulsed proton clinical beams.

A number of designs have been proposed for ridge filters and range modulators used in proton therapy to modify the beam in order to spread out the Bragg peak. Despite the variety of solutions, no simple design capable of providing large fields and easy variation of the spread out Bragg peak (SOBP) length in a pulsed beam has been developed. We propose a compact ridge filter that can be used in a proton beam of any time structure.

Investigation of applicability of alanine and radiochromic detectors to dosimetry of proton clinical beams.

Cancer therapy studies using proton accelerators are underway in several major medical centers in the U.S., Russia, Japan and elsewhere.

Relative biological effectiveness of proton medical beam at Moscow synchrotron determined by the Chinese hamster cells assay.

Purpose: Assessment of relative biological effectiveness (RBE) of the proton medical beam at Moscow synchrotron.

Methods And Materials: The study was performed at Moscow proton medical facility (Institute for Theoretical and Experimental Physics). Relative biological effectiveness of the synchrotron proton beam was assessed at the entry of the unmodulated 179 MeV beam and in the center of spread out Bragg peak (SOBP), from measurements of the survival of Chinese hamster cells (clone 431).